Illumina, General Atlantic and Viking Global Investors supplied $70m for Ginkgo Bioworks, a cell programming technology provider that has now raised more than $789m altogether.
US-based microbe engineering services provider Ginkgo Bioworks has received $70m in funding from genomics technology producer Illumina, growth equity firm General Atlantic and hedge fund manager Viking Global Investors.
Spun out of Massachusetts Institute of Technology in 2009, Ginkgo has developed cell programming technology that is capable of growing organisms for industrial applications such as nutritional products, consumer goods and fragrances.
Gingko has itself established a series of spinoffs including microbiome technology producer Joyn Bio and alternative protein developer…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
